Clinical Trial: Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07338175) titled 'Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage' on Jan. 03.

Brief Summary: This is a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. It aims to evaluate the efficacy and safety of oral minocycline in patients with acute spontaneous intracerebral hemorrhage within 48 hours of onset.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Intracerebral Hemorrhage

Intervention: DRUG: Minocycline hydrochloride capsules

50 mg per capsule, containing 50mg of Minocycline Hydrochloride

DRUG: Placebo capsules of Minocycline hydrochloride capsules

50 ...